BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aquinox Pharmaceuticals 

5600 Parkwood Way
Suite 430
Richmond  British Columbia  V6V 2M2  U.S.A.
Phone: 604-629-9223 Fax: 604-295-4748


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Aquinox Pharmaceuticals (AQXP) Announces Second Quarter 2014 Financial Results 8/11/2014 5:04:30 PM
Aquinox Pharmaceuticals (AQXP) To Present At Canaccord Genuity 34th Annual Growth Conference 8/6/2014 4:35:50 PM
Aquinox Pharmaceuticals (AQXP) To Announce Second Quarter Financial Results And Host Conference Call On August 11, 2014 8/5/2014 3:44:37 PM
Aquinox Pharmaceuticals (AQXP) Announces Expansion Of Ongoing Phase 2 Trials Of AQX-1125, Including Acceptance Of U.S. IND 6/2/2014 9:22:38 AM
Aquinox Pharmaceuticals (AQXP) To Present At Upcoming Investor Conferences 5/21/2014 9:15:30 AM
Aquinox Pharmaceuticals (AQXP) Announces Closing Of Initial Public Offering 3/12/2014 8:32:46 AM
Vancouver's Aquinox Pharmaceuticals (AQXP) Prices Upsized IPO At $11, Raises $46 Million 3/7/2014 9:32:24 AM
Aquinox Pharmaceuticals Completes $18 Million Series C Financing 4/3/2013 7:33:15 AM
Aquinox Pharmaceuticals Receives Regulatory Clearance to Initiate First Clinical Study of AQX-1125, A Novel Oral Anti-Inflammatory Compound 1/5/2011 9:58:36 AM
Aquinox Pharmaceuticals Appoints Csaba Szabo, M.D., Ph.D., Vice President, Research and Chief Scientific Officer 9/15/2010 12:00:57 PM
12